Clinical Advisor |
Severe Atopic Eczema Tied to Higher CV Disease Risk
Clinical Advisor HealthDay News — Adults with severe atopic eczema are at increased risk of cardiovascular disease, according to a study published online May 23 in The BMJ. Richard J. Silverwood, PhD, from the London School of Hygiene and Tropical Medicine, and … |
Tag Archives: atopic
Severe Atopic Eczema Tied to Higher CV Disease Risk – Clinical Advisor
Clinical Advisor |
Severe Atopic Eczema Tied to Higher CV Disease Risk
Clinical Advisor HealthDay News — Adults with severe atopic eczema are at increased risk of cardiovascular disease, according to a study published online May 23 in The BMJ. Richard J. Silverwood, PhD, from the London School of Hygiene and Tropical Medicine, and … |
Severe Atopic Eczema Tied to Higher CV Disease Risk – Clinical Advisor
Clinical Advisor |
Severe Atopic Eczema Tied to Higher CV Disease Risk
Clinical Advisor HealthDay News — Adults with severe atopic eczema are at increased risk of cardiovascular disease, according to a study published online May 23 in The BMJ. Richard J. Silverwood, PhD, from the London School of Hygiene and Tropical Medicine, and … |
Gene identified as having a role in suppressing atopic dermatitis
The transcription factor “retinoid-related orphan receptor-alpha” (RORA) has been identified as a regulator of T regulatory (Treg) genes responsible for suppressing allergic skin inflammation, researchers report.
Modern medicine – dermatology
Methotrexate outperforms cyclosporine in atopic dermatitis study
The duration of methotrexate administration proves to be longer than that of cyclosporine in atopic dermatitis, according to a small study that compared the two first-line immunosuppressive treatments for atopic dermatitis.
Dermatology Times – Dermatology
Atopic dermatitis: From guidelines to practice
As some elements of current atopic dermatitis guidelines are now outdated due to the speed of clinical advances in the field, experts are bridging the gap with new consensus statements and scientific updates that tackle key questions regarding topical and systemic therapy.
Modern medicine – American Academy of Dermatology
AAD meeting preview for atopic dermatitis treatments
New data and status updates for atopic dermatitis treatments in clinical trials will be presented at the American Academy of Dermatology annual meeting in San Diego this week. In this article, we offer some highlights.
Dermatology Times – Dermatology
Patient dosing begins for Phase 2 study of new topical gel for atopic dermatitis
Cornerstone therapy in atopic dermatitis
Moisturizers were described as the “cornerstone of therapy” in atopic dermatitis in the 2014 AAD guidelines for topical therapies in atopic dermatitis, but the products differ greatly by ingredients which can improve the condition or make it worse.
Dermatology Times – Dermatology